
AstraZeneca LSE London
AstraZeneca PLC (AZNxlon) is a British-Swedish multinational biopharmaceutical company headquartered in Cambridge, United Kingdom. The company researches, develops, manufactures and commercialises prescription medicines across oncology, cardiovascular, renal & metabolism, respiratory & immunology, and rare disease therapy areas. Key products include Tagrisso, Imfinzi, Farxiga and Symbicort. AstraZeneca is a major constituent of the FTSE 100 index on the London Stock Exchange and is also listed on Nasdaq and the Stockholm exchange. The company is one of the world's largest pharmaceutical groups by revenue and a global leader in oncology innovation.
Start trading
AstraZeneca now
At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.
.png?width=2000&height=1471&name=Update%20I2M%20Telefoon%20(1).png)